Difference between revisions of "Pharm Tech Minutes 2012.10.10"
(Created page with "== Participants == * Demarmels, Marco (Lake Griffin, LLC) * Gumpper, Karl (ASHP) * Letellier, Simon (EAHP) * Robberecht, Marc (Agfa Healthcare) == Summary == The IHE Pharmacy ...") |
|||
| Line 43: | Line 43: | ||
Define the boundaries. | Define the boundaries. | ||
| + | |||
| + | The procurement actorand associated actions inside the hospital need to ... | ||
| + | |||
| + | === Traceable items === | ||
| + | |||
| + | Refer to general sequence diagram, but mention inclusion of identification data. | ||
| + | |||
| + | Should this be a dedicated use case or should we mention the tracable items follow the same flows, with inclusion of details in the messages. | ||
| + | |||
| + | A detailed storyboard will be delivered to decide whether this is a dedicated use case | ||
| + | |||
| + | |||
| + | Need to implement production of medication and CMA. | ||
Revision as of 08:33, 10 October 2012
Participants
- Demarmels, Marco (Lake Griffin, LLC)
- Gumpper, Karl (ASHP)
- Letellier, Simon (EAHP)
- Robberecht, Marc (Agfa Healthcare)
Summary
The IHE Pharmacy Supply Chain white paper is reviewed during the session.
Definitions
- definitions are useful for the use cases.
Will be check and fill with the IHE Glossary, HMW definitions (and Wikipedia ?).
Do we need a glossary in one place in the document ?
Preparation
Discussion on the word Preparation : Allocation fit more with the definition.
Confusing with HMW "Preparation report - Pharm H3"
Dispense is more from Pharmacy to ADC.
Prepartion is "make the medication" : mix, repacking, combining
Allocation ==> making ready at the patient's side.
Ward stock refills
Replacing a drug by a new equivalent : do we really need a dedicated sequence diagramm ?
Have to detail the sequence diagramm to choose.
Procurement
Do we need to receive the procurement message ?
Is it out of scope?
Define the boundaries.
The procurement actorand associated actions inside the hospital need to ...
Traceable items
Refer to general sequence diagram, but mention inclusion of identification data.
Should this be a dedicated use case or should we mention the tracable items follow the same flows, with inclusion of details in the messages.
A detailed storyboard will be delivered to decide whether this is a dedicated use case
Need to implement production of medication and CMA.